Skip to main content
Item(s) Added to Cart

0 item(s) Subtotal $0,00

Treating the Trifecta: Mast Cell Disease, Hypermobile Ehlers-Danlos Syndrome and Postural Orthostatic Tachycardia Syndrome

Treating the Trifecta: Mast Cell Disease, Hypermobile Ehlers-Danlos Syndrome and Postural Orthostatic Tachycardia Syndrome
FNCE 2025 Buy 2 Get 1 Free
Read Details

Buy 2 get 1 free on FNCE® 2025 session recordings only; FNCE® 2025 collections are excluded. Discount will be auto-applied – no code needed.

Treating the Trifecta: Mast Cell Disease, Hypermobile Ehlers-Danlos Syndrome and Postural Orthostatic Tachycardia Syndrome

Your Price $10.00 - $54.00

This presentation will focus on Mast Cell Disease (MCD), hypermobile Ehlers-Danlos Syndrome (hEDS), and Postural Orthostatic Tachycardia Syndrome (POTS), highlighting the unique nutritional considerations associated with each condition. Participants will explore evidence-based dietary approaches and specialized hydration strategies to manage common symptoms, particularly due to increased diagnoses of post-Covid conditions (PCC).

By providing practical tools for personalized nutrition planning, this course empowers RDNs and NDTRs to make informed dietary recommendations, improving patient quality of life and symptom management for individuals navigating these overlapping health conditions.

Product Publish Details

Release Date: October 15, 2025

SKU: FNCE25212

CPEU: 1.50 (Valid Until September 16, 2028)

Learning Objectives

  • Describe the pathophysiology and common symptoms of Mast Cell Disease (MCD), hypermobile Ehlers-Danlos Syndrome (hEDS), and Postural Orthostatic Tachycardia Syndrome (POTS), understanding their nutritional implications.
  • Explain the complex symptomatology of MCD relating to diet, including identifying common food triggers and intolerances in order to facilitate meal planning and symptom reduction.
  • Identify specific strategies to manage symptoms of MCD, hEDS, and POTS, including diet modifications and hydration protocols to improve quality of life and reduce symptoms.

Performance Indicators

  • 9.1.1 Interprets and applies the appropriate evidence-based literature and standards for determining nutritional needs of target audiences.
  • 11.4.5 Implements, initiates, or modifies nutrition-related pharmacotherapy orders that address client/patient needs.
  • 2.1.6 Acknowledges the differences and complexities of individuals, including students/interns, patients and clients, and populations (e.g., individuals affected by specific conditions or illnesses and disability identities).

Placeholder Headshot

Renee Euler, MS, RDN

Moderator

Placeholder Headshot

Nicole (Niki) Strealy, RDN, LD

Speaker

Placeholder Headshot

Bonnie Nasar, RDN

Speaker

Check Out Our Current Sales

From seasonal specials celebrating commemorative events and awareness campaigns to sales on soon-to-expire CPE activities and book titles for which new editions are just around the corner, don't miss this opportunity to grab cutting-edge resources at discounted prices.